Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | AMG 757 |
Synonyms | |
Therapy Description |
AMG 757 is a bispecific antibody that targets CD3 on T-cells and delta-like protein 3 (DLL3) expressed by tumor cells (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
AMG 757 | AMG757|AMG-757 | CD3 Antibody 56 | AMG 757 is a bispecific antibody that targets CD3 on T-cells and delta-like protein 3 (DLL3) expressed by tumor cells (PMID: 31215500). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04702737 | Phase I | AMG 757 | A Study of AMG 757 in Participants With Neuroendocrine Prostate Cancer | Recruiting | USA | FRA | ESP | BEL | AUT | 4 |
NCT05060016 | Phase II | AMG 757 | A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC) | Recruiting | USA | ITA | FRA | ESP | DEU | BEL | AUT | 9 |
NCT03319940 | Phase I | AMG 757 | Study Evaluating Safety, Tolerability and PK of AMG 757 in Adults With Small Cell Lung Cancer | Recruiting | USA | FRA | ESP | DEU | AUT | 6 |